Dr. Eric Simoes, from the Children's Hospital Colorado, worked with Pfizer and has been working on RSV prevention for decades. He calls this approval fantastic news. "My only hope is that we can get these vaccines not only in the U.S., but also to children in developing countries that need it the most," says Simoes.